Essilor - Q1 2006 Sales
April 20 2006 - 1:32AM
PR Newswire (US)
A Good Start to the Year CHARENTON-LE-PONT, France, April 20
/PRNewswire-FirstCall/ -- Essilor (OTC:ESLOF) , the world leader in
ophthalmic optics, today announced its consolidated revenue for the
three months ended March 31, 2006: In euros millions March 31, 2006
March 31, 2005 % Change Like-for-like growth Revenue 692.8 570.0
21.5% 11.5% Europe 300.0 269.1 11.5% 9.8% North America 309.1 238.7
29.5% 12.4% Asia Pacific 60.3 47.0 28.4% 14.3% Latin America 23.4
15.2 54.1% 17.3% Revenue for the first three months of 2006 was up
11.5% like-for-like and 21.5% as reported, in comparison with a
relatively weak prior-year period. Acquisitions made in 2005 and
early 2006 added 4% to reported growth, while the currency effect
was a positive 6%, primarily reflecting the increase in the US
dollar, Canadian dollar and Brazilian real against the euro
compared with first-quarter 2005. In a generally expanding market,
the Group reported significant growth in unit sales and a favorable
shift in the product mix. In particular, the new Varilux Physio(R)
progressive lens, which was launched in high-index materials during
the first quarter, has proven highly popular with consumers and
eyecare professionals alike. As a result, business improved in
Europe, while continuing to enjoy robust growth in North America,
Asia and Latin America. Recent Acquisitions Essilor continued to
acquire new companies in the first quarter: - In New Zealand,
Wellington-based Prolab was acquired and the stake in
Christchurch-based Olab was raised to 50%. These two prescription
laboratories have combined revenue of US$4 million. - In India, the
Group acquired the assets of Delta CNC, a laboratory based in
Ahmedabad. - In the United States, Uniscoat Inc., a coating
facility in California, and PerfeRx Optical Co., Inc., a Varilux(R)
distributor in Massachusetts, were both acquired. The two companies
reported total revenue of US$7 million. In all, Essilor has
acquired ten companies since January 1, representing full-year
revenue of EUR26 million. A conference call will be held today at
10:00 a.m. Paris time. The number to dial is: +44(0)161-601-89-20
The conference will be available for later listening at:
http://hosting.3sens.com/Essilor/20060420-2C89A437/en Next
financial announcement First-half 2006 revenue: July 20, 2006
Essilor International is the world leader in ophthalmic optical
products, offering a wide range of lenses under the flagship
Varilux(R), Crizal(R), Airwear(R) and Essilor(R) brands to correct
myopia, hyperopia, presbyopia and astigmatism. Essilor operates
worldwide through 16 production sites, 215 lens finishing
laboratories and local distribution networks. The Essilor share
trades on the Euronext Paris market and is included in the CAC 40
index (ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF FP).
Investor Relations and Financial Communication Veronique Gillet
Phone: +33(0)1-49-77-42-16 DATASOURCE: Essilor CONTACT: Investor
Relations and Financial Communication, Veronique Gillet, Phone:
+33(0)1-49-77-42-16
Copyright